Company number 08970885
Status Active
Incorporation Date 1 April 2014
Company Type Private Limited Company
Address 14 WEST END CLOSE, STEEPLE CLAYDON, BUCKINGHAM, MK18 2LN
Home Country United Kingdom
Nature of Business 74909 - Other professional, scientific and technical activities n.e.c.
Phone, email, etc
Since the company registration seven events have happened. The last three records are Confirmation statement made on 1 April 2017 with updates; Total exemption small company accounts made up to 31 March 2016; Annual return made up to 1 April 2016 with full list of shareholders
Statement of capital on 2016-04-12
GBP 10
. The most likely internet sites of PERPETUATE PHARMA LIMITED are www.perpetuatepharma.co.uk, and www.perpetuate-pharma.co.uk. The predicted number of employees is 1 to 10. The company’s age is eleven years and eight months. Perpetuate Pharma Limited is a Private Limited Company.
The company registration number is 08970885. Perpetuate Pharma Limited has been working since 01 April 2014.
The present status of the company is Active. The registered address of Perpetuate Pharma Limited is 14 West End Close Steeple Claydon Buckingham Mk18 2ln. . PRILL, David is a Director of the company. PRILL, Fiona Julie is a Director of the company. The company operates in "Other professional, scientific and technical activities n.e.c.".
Current Directors
Persons With Significant Control
Mr David Prill
Notified on: 6 April 2016
69 years old
Nature of control: Ownership of shares – More than 50% but less than 75%
PERPETUATE PHARMA LIMITED Events
03 Apr 2017
Confirmation statement made on 1 April 2017 with updates
10 Jun 2016
Total exemption small company accounts made up to 31 March 2016
12 Apr 2016
Annual return made up to 1 April 2016 with full list of shareholders
Statement of capital on 2016-04-12
11 May 2015
Annual return made up to 1 April 2015 with full list of shareholders
Statement of capital on 2015-05-11
01 May 2015
Total exemption small company accounts made up to 31 March 2015
12 Dec 2014
Current accounting period shortened from 30 April 2015 to 31 March 2015
01 Apr 2014
Incorporation
Statement of capital on 2014-04-01
-
MODEL ARTICLES ‐
Model articles adopted